Wednesday, June 18, 2025

June 18, 2025 at 04:17PM PRIVIGEN

For the treatment of:

Primary humoral immunodeficiency (PI)

Chronic immune thrombocytopenic purpura (ITP) in patients age 15 years and older

Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/AZ5DVRG

No comments:

Post a Comment